Who
Chad Oh
Chief Medical Officer
Company insider
Files Form 4 as: Chief Medical Officer, AEON Biopharma.
In numbers
- Trades disclosed
- 11
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 21 Jul 2023
- Last trade
- 4 Mar 2026
- Last filed
- 11 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 4 Mar 2026filed 11 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —1,316,872 at $0.00 | filing |
| 4 Mar 2026filed 11 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —1,316,872 at $0.00 | filing |
| 17 Feb 2026filed 11 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —862,500 at $0.00 | filing |
| 17 Feb 2026filed 11 Mar 2026 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —862,500 at $0.00 | filing |
| 21 May 2025filed 23 May 2025 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —1,316,872 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —512,673 at $0.00 | filing |
| 31 Aug 2024filed 4 Sep 2024 | AEON AEON BiopharmaBiotechnology | SEC FORM 4 Code A | —192,117 at $0.00 | filing |
| 19 Mar 2024filed 21 Mar 2024 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —86,720 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —145,588 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —115,151 at $0.00 | filing |
| 21 Jul 2023filed 24 Jul 2023 | AEON AEON Biopharmaoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,428 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.